is this based on MoA of ANTH's drug theoretically being superior in some way
yes
but early, it could be better, or just as good. or could have a safety issue. But I would prefer to have all my eggs in that basket than have them spend money on an acs trial that I think has a 95 percent chance of failing
Market Data 
Markets 
AI
